DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment.

Arthritis research & therapy

Volumn 7, Issue 5, 2005, Pages

  Vander Cruyssen, Bert ^a   Van Looy, Stijn ^a   Wyns, Bart ^a   Westhovens, Rene ^a   Durez, Patrick ^a   Van den Bosch, Filip ^a   Veys, Eric M ^a   Mielants, Herman ^a   De Clerck, Luc ^a   Peretz, Anne ^a   Malaise, Michel ^a   Verbruggen, Leon ^a   Vastesaeger, Nathan ^a   Geldhof, Anja ^a   Boullart, Luc ^a   De Keyser, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY;

AREA UNDER THE CURVE; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DECISION MAKING; DRUG COMBINATION; HOSPITALIZATION; HUMAN; MULTICENTER STUDY; PHYSICIAN; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; ROC CURVE; VALIDATION STUDY;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; COHORT STUDIES; DRUG THERAPY, COMBINATION; HUMANS; JUDGMENT; METHOTREXATE; PHYSICIANS; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 25144513375     PISSN: None     EISSN: 14786362     Source Type: Journal    
DOI: None     Document Type: Article

References (0)